Compare CAVA & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CAVA | BRKR |
|---|---|---|
| Founded | 2006 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.6B | 9.0B |
| IPO Year | 2023 | 2000 |
| Metric | CAVA | BRKR |
|---|---|---|
| Price | $60.71 | $58.31 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 23 | 13 |
| Target Price | ★ $91.00 | $48.54 |
| AVG Volume (30 Days) | ★ 2.9M | 1.8M |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.58% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.39 | N/A |
| Revenue | $1,179,664,000.00 | ★ $1,895,600,000.00 |
| Revenue This Year | $25.71 | $6.30 |
| Revenue Next Year | $20.57 | $3.81 |
| P/E Ratio | $158.44 | ★ N/A |
| Revenue Growth | ★ 22.41 | N/A |
| 52 Week Low | $43.41 | $29.84 |
| 52 Week High | $98.79 | $65.30 |
| Indicator | CAVA | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 38.12 | 51.86 |
| Support Level | $60.12 | $54.54 |
| Resistance Level | $62.16 | $63.93 |
| Average True Range (ATR) | 2.73 | 2.53 |
| MACD | -0.87 | 0.11 |
| Stochastic Oscillator | 7.58 | 51.01 |
Cava Group Inc owns and operates a chain of restaurants. It operates a Mediterranean-inspired fast-casual restaurant brand offering menu items. The company's dips, spreads, and dressings are centrally produced and sold in grocery stores. The company's operations are conducted as two reportable segments: i) CAVA: It includes the operations of all company-owned CAVA restaurants, and ii) CAVA Foods: It includes the production of dips, spreads, and certain dressing bases used in CAVA restaurants as well as sales from the Company's consumer packaged goods business. The company generates the majority of its revenue from the CAVA segment.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.